journal article·2013-05-28Open access

Biodegradation of Iron Oxide Nanocubes: High-Resolution In Situ Monitoring

Lénaic Lartigue, Damien Alloyeau, Jelena Kolosnjaj-Tabi, Yasir Javed, Pablo Guardia, Andreas Riedinger, Christine Péchoux, Teresa Pellegrino, Claire Wilhelm, Florence Gazeau

ACS Nano· Volume 7· Issue 5

Abstract

The long-term fate of nanomaterials in biological environment represents a critical matter, which determines environmental effects and potential risks for human health. Predicting these risks requires understanding of nanoparticle transformations, persistence, and degradation, some issues somehow ignored so far. Safe by design, inorganic nanostructures are being envisioned for therapy, yet fundamental principles of their processing in biological systems, change in physical properties, and in situ degradability have not been thoroughly assessed. Here we report the longitudinal visualization of iron oxide nanocube transformations inflicted by the intracellular-like environment. Structural degradation of individual nanocubes with two different surface coatings (amphiphilic polymer shell and polyethylene glycol ligand molecules) was monitored at the atomic scale with aberration-corrected high-resolution transmission electron microscopy. Our results suggest that the polymer coating controls surface reactivity and that availability and access of chelating agents to the crystal surface govern the degradation rate. This in situ study of single nanocube degradation was compared to intracellular transformations observed in mice over 14 days after intravenous injection, revealing the role of nanoparticle clustering, intracellular sorting within degradation compartments, and iron transfer and recycling into ferritin storage proteins. Our approach reduces the gap between in situ nanoscale observations in mimicking biological environments and in vivo real tracking of nanoparticle fate.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Iron Metabolism and Disorders · Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Inserm U970, Paris Cardiovascular Research Center-PARCC/Université Paris-Descartes, 56 rue Leblanc, 75015 France

Istituto Italiano di Tecnologia, via Morego 30, 16163 Genova, Italy

UR1196 Génomique et Physiologie de la Lactation, INRA, Plateau de Microscopie Electronique 78352 Jouy-en-Josas, France

References (49)

Show source-provided references
1. Lowry G. V. · Environ. Sci. Technol. · 2012 · 46 · 689310.1021/es300839e ↗
2. Thomas C. R. · ACS Nano · 2011 · 5 · 1310.1021/nn1034857 ↗
3. Rivera-Gil P. · Nano Lett. · 2009 · 9 · 439810.1021/nl902697j ↗
4. Zhou X. · Nat. Nanotechnol. · 2012 · 7 · 23710.1038/nnano.2012.18 ↗
5. Levard C. · Environ. Sci. Technol. · 2012 · 46 · 690010.1021/es2037405 ↗
6. Xia T. · ACS Nano · 2011 · 5 · 122310.1021/nn1028482 ↗
7. George S. · ACS Nano · 2012 · 6 · 374510.1021/nn204671v ↗
8. Cedervall T. · Proc. Natl. Acad. Sci. U.S.A. · 2007 · 104 · 205010.1073/pnas.0608582104 ↗
9. Casals E. · ACS Nano · 2010 · 4 · 362310.1021/nn901372t ↗
10. Lundqvist M. · ACS Nano · 2011 · 5 · 750310.1021/nn202458g ↗
11. Dobrovolskaia M. A. · Mol. Pharmaceutics · 2008 · 5 · 48710.1021/mp800032f ↗
12. Lartigue L. · ACS Nano · 2012 · 6 · 266510.1021/nn300060u ↗
13. Fayol D. · Adv. Healthcare Mater. · 2012 · 2 · 31310.1002/adhm.201200294 ↗
14. Ohkuma S. · Proc. Natl. Acad. Sci. U.S.A. · 1978 · 75 · 332710.1073/pnas.75.7.3327 ↗
15. Weissleder R. · AJR Am. J. Roentgenol. · 1989 · 152 · 16710.2214/ajr.152.1.167 ↗
16. Arbab A. S. · NMR Biomed. · 2005 · 18 · 38310.1002/nbm.970 ↗
17. Okon E. · Lab. Invest. · 1994 · 71 · 895
18. Levy M. · Nanotechnology · 2010 · 21 · 39510310.1088/0957-4484/21/39/395103 ↗
19. Levy M. · Nanoscale · 2011 · 3 · 440210.1039/c1nr10778j ↗
20. Levy M. · Biomaterials · 2011 · 32 · 398810.1016/j.biomaterials.2011.02.031 ↗
21. Guardia P. · ACS Nano · 2012 · 6 · 308010.1021/nn2048137 ↗
22. Bae K. H. · ACS Nano · 2012 · 6 · 526610.1021/nn301046w ↗
23. Noh S.-h. · Nano Lett. · 2012 · 12 · 371610.1021/nl301499u ↗
24. Lee N. · Nano Lett. · 2012 · 12 · 312710.1021/nl3010308 ↗
25. Lee N. · Proc. Natl. Acad. Sci. U.S.A. · 2011 · 108 · 266210.1073/pnas.1016409108 ↗
26. Guardia P. · Langmuir · 2010 · 26 · 584310.1021/la903767e ↗
27. Kovalenko M. V. · J. Am. Chem. Soc. · 2007 · 129 · 635210.1021/ja0692478 ↗
28. Wang Z. L. · J. Phys. Chem. B · 2000 · 104 · 115310.1021/jp993593c ↗
29. Van Oosterhout G. W. · Nature · 1958 · 181 · 4410.1038/181044a0 ↗
30. Pellegrino T. · Nano Lett. · 2004 · 4 · 70310.1021/nl035172j ↗
31. Di Corato R. · J. Mater. Chem. · 2008 · 18 · 199110.1039/b717801h ↗
32. Amstad E. · Small · 2009 · 5 · 133410.1002/smll.200801328 ↗
33. Gabizon A. · Clin. Pharmacokinet. · 2003 · 42 · 41910.2165/00003088-200342050-00002 ↗
34. Tao A. R. · Small · 2008 · 4 · 31010.1002/smll.200701295 ↗
35. Gazeau F. · J. Magn. Magn. Mater. · 1999 · 202 · 53510.1016/S0304-8853(99)00156-0 ↗
36. Schulze E. · Invest. Radiol. · 1995 · 30 · 60410.1097/00004424-199510000-00006 ↗
37. Loubery S. · Traffic · 2008 · 9 · 49210.1111/j.1600-0854.2008.00704.x ↗
38. Gálvez N. · J. Am. Chem. Soc. · 2008 · 130 · 806210.1021/ja800492z ↗
39. Quintana C. · J. Struct. Biol. · 2004 · 147 · 16610.1016/j.jsb.2004.03.001 ↗
40. Hower V. · Mol. BioSyst. · 2009 · 5 · 42210.1039/b816714c ↗
41. Papanikolaou G. · Toxicol. Appl. Pharmacol. · 2005 · 202 · 19910.1016/j.taap.2004.06.021 ↗
42. Liu X. · Acc. Chem. Res. · 2005 · 38 · 16710.1021/ar0302336 ↗
43. Theil E. C. · Curr. Opin. Chem. Biol. · 2011 · 15 · 30410.1016/j.cbpa.2011.01.004 ↗
44. Kedziorek D. A. · Magn. Reson. Med. · 2010 · 63 · 103110.1002/mrm.22290 ↗
45. Riedinger A. · Nano Lett. · 2011 · 11 · 313610.1021/nl2011627 ↗
46. Alloyeau D. · Appl. Phys. Lett. · 2012 · 101 · 12192010.1063/1.4754111 ↗
47. Ricolleau C. · JEOL News · 2012 · 47 · 2
48. Alloyeau D. · Chem. Commun. · 2011 · 47 · 937510.1039/c1cc13654b ↗
49. Fortin J. P. · J. Am. Chem. Soc. · 2007 · 129 · 262810.1021/ja067457e ↗